A Japan-made supplement entering Malaysia can land in either of two very different regulatory tracks, and the two tracks are not interchangeable — one requires full product registration before a single unit is sold, the other is closer to standard food compliance. Getting the classification wrong at the outset is the single most common cause of delay for a new brand entering this market.
This guide covers who regulates a Japan-made supplement in Malaysia, how the food-versus-supplement classification is decided, what NPRA registration and the MAL number involve, and what a Japanese factory can and cannot do to help.
💬 Planning to bring a Japan-made supplement into Malaysia? We help you prepare the specification and documents your Malaysian registration holder will need. Japan-made supplement OEM.
Two regulators, one classification decision
Malaysia’s Food Safety and Quality Division (FSQD) regulates conventional food, while the National Pharmaceutical Regulatory Agency (NPRA) regulates traditional and health supplement products, and a joint committee decides which applies to a borderline product.
| Regulator | Scope | What it means for a Japan-made supplement |
|---|---|---|
| FSQD (Food Safety and Quality Division, Ministry of Health) | Conventional food, including 100% food-ingredient products and items in ordinary food form (biscuit, confectionery, gummy, noodle, etc.) | A product sold in conventional food format, without a medicinal or health claim |
| NPRA (National Pharmaceutical Regulatory Agency) | Traditional products and health supplements, including products with a medicinal or health claim, or containing ingredients with high pharmacological or therapeutic potency | A capsule, tablet or powder-format supplement, or any product carrying a health claim |
Because many Japanese formulas sit at this boundary — a capsule containing an ingredient also found in ordinary food, for instance — Malaysia formed the Committee for the Classification of Food-Drug Interface (FDI) Products in 2000, jointly staffed by NPRA and FSQD, specifically “to better define and regulate the FDI products” and “assist both Divisions in classifying, in a consistent manner, an application from the industry which is not clearly defined either as a food or drug product.” A company can apply to this committee to get an authoritative classification before committing to a registration pathway. As a general rule, an FDI product without ingredients from the Negative List for FDI and carrying a medicinal or health claim is regulated by NPRA; the same product without a medicinal or health claim is regulated by FSQD.
NPRA registration and the MAL number
Most capsule, tablet or powder-format supplements sold in Malaysia need NPRA product registration before sale, and an approved product is identified by a “MAL” registration number on the label.
Products that NPRA classifies as traditional products or health supplements — a category that explicitly includes dietary supplements — must be registered with the Drug Control Authority (DCA) before they can be marketed in Malaysia. For traditional preparations and health supplements specifically, the DCA’s evaluation is described as focused on quality and safety rather than the full efficacy evaluation applied to conventional pharmaceuticals.
Once the DCA clears a submission, it issues a registration number in the format “MAL” followed by eight digits and a closing letter that indicates the registration category (for example, ending in T, A, X or N). This number must appear on the product’s packaging or label as evidence of the registration. A foreign brand owner, including a Japan-made brand, cannot hold this registration directly — Malaysia requires a locally registered agent to act as the registration holder and manage the submission and any subsequent regulatory correspondence.
What this means for a Japanese formula
The Japanese factory supplies the specification, testing and documentation the Malaysian registration holder needs; the registration itself is filed and held locally, not from Japan.
The local importer or product registration holder — not the Japanese manufacturer — carries the NPRA registration or the FSQD notification. A Japanese GMP-certified partner factory can support that process with a full specification sheet (every ingredient and its amount), a Certificate of Analysis confirming the batch matches specification, and a Certificate of Free Sale confirming the product is legally sold as a food in Japan, which is commonly requested as supporting evidence in an NPRA submission. Heavy-metal and microbial contamination testing to the traditional-product/health-supplement quality standards — mercury, arsenic, lead and cadmium limits, plus microbial and, for solid dosage forms, disintegration testing — are documented through the same Certificate of Analysis.
💬 Need a specification pack ready for your Malaysian registration holder to submit to NPRA or FSQD? Tell us your product and intended claims.
Label language and claims
A Malaysian label must be in Bahasa Malaysia (English may be included alongside it), and any health claim must sit within what the product’s registration or notification actually permits.
Health supplements are foods, not medicines, and are not a substitute for medical treatment. Whether NPRA-registered or FSQD-notified, the product’s approved status and permitted claim wording — not the Japanese domestic label’s claims — govern what can appear on the Malaysian label, since Japan’s own Foods with Function Claims or Foods with Nutrient Function Claims wording has no standing in Malaysia.
Before you ask for a quotation
- Establish, ideally through the FDI classification service, whether your product will fall under NPRA or FSQD
- Confirm your local registration holder or notifying party in Malaysia, since the registration cannot be held from Japan
- Decide what health claim, if any, you intend to make, since this affects the classification itself
- List the documents you will need from the factory: specification sheet, Certificate of Analysis, Certificate of Free Sale
- Confirm the label will be prepared in Bahasa Malaysia
💬 Ready to prepare documents for NPRA or FSQD submission? Send us your product details and intended market claims.
Frequently asked questions
1. Does every Japan-made supplement need NPRA registration in Malaysia?
Not automatically. It depends on dosage form and whether a medicinal or health claim is made. A capsule or tablet-format supplement with a health claim is typically an NPRA matter; a product in conventional food form without such a claim may instead fall under FSQD. Malaysia’s joint FDI classification committee can determine the correct pathway for a borderline product.
2. What is a MAL number?
The registration number the Drug Control Authority assigns once a product clears NPRA registration — “MAL” followed by eight digits and a closing letter indicating the category. It must appear on the approved product’s label.
3. Can the Japanese factory register the product with NPRA on our behalf?
No. Malaysia requires a locally registered agent to act as the registration holder. The Japanese factory instead supplies the specification, Certificate of Analysis and Certificate of Free Sale that support the local holder’s submission.
4. What language must the Malaysian label use?
Bahasa Malaysia, with English or other languages permitted alongside it depending on the product category and applicable labelling regulation.
5. Is a food-classified Japan-made ingredient exempt from all Malaysian rules?
No — it still falls under FSQD’s food regulations, which set their own composition, safety and labelling requirements even without NPRA product registration.
Sources: National Pharmaceutical Regulatory Agency, “Product Classification Guideline,” npra.gov.my/index.php/en/classification-guideline/product-classification-guideline.html; National Pharmaceutical Regulatory Agency, “FAQ: Product Registration,” npra.gov.my (FAQ section); Food Safety and Quality Division, Ministry of Health Malaysia, Food Act 1983 and Food Regulations 1985, as referenced in NPRA’s FDI classification guideline. Checked on 25 September 2026.